Financhill
Sell
32

ORIC Quote, Financials, Valuation and Earnings

Last price:
$8.43
Seasonality move :
-19.91%
Day range:
$8.29 - $8.62
52-week range:
$3.90 - $14.93
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.02x
Volume:
587.8K
Avg. volume:
1.4M
1-year change:
2.93%
Market cap:
$821M
Revenue:
--
EPS (TTM):
-$1.73

Earnings Data

Next earnings date for ORIC
Feb 17
2026
Most recent earnings per share
-$0.33
Beat by $0.07
(Nov 13/2025)
Consensus Estimate
-$0.40
(Nov 13/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ORIC Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/17/2026 Q4 -- -- -- -$0.37 --
11/13/2025 Q3 -- -- -$0.33 -$0.40 $0.07
08/12/2025 Q2 -- -- -$0.47 -$0.44 -$0.02
05/05/2025 Q1 -- -- -$0.42 -$0.51 $0.08
02/19/2025 Q4 -- -- -$0.51 -$0.51 -$0.01
11/12/2024 Q3 -- -- -$0.49 -$0.47 -$0.02
08/12/2024 Q2 -- -- -$0.45 -$0.41 -$0.05
05/06/2024 Q1 -- -- -$0.37 -$0.43 $0.06
03/11/2024 Q4 -- -- -$0.49 -$0.48 -$0.02
11/06/2023 Q3 -- -- -$0.44 -- --
08/10/2023 Q2 -- -- -$0.50 -- --
05/08/2023 Q1 -- -- -$0.53 -- --
03/21/2023 Q4 -- -- -$0.52 -- --
11/07/2022 Q3 -- -- -$0.63 -- --
08/11/2022 Q2 -- -- -$0.51 -- --
05/09/2022 Q1 -- -- -$0.59 -- --
03/21/2022 Q4 -- -- -$0.58 -- --
11/08/2021 Q3 -- -- -$0.47 -- --
08/10/2021 Q2 -- -- -$0.57 -- --
05/06/2021 Q1 -- -- -$0.45 -- --
03/23/2021 Q4 -- -- -$0.84 -- --
11/05/2020 Q3 -- -- -$0.84 -- --
08/05/2020 Q2 -- -- -$0.51 -- --
05/20/2020 Q1 -- -- -$0.30 -- --
12/31/2019 Q4 -- -- -$0.44 -- --
09/30/2019 Q3 -- -- -$0.22 -- --
06/30/2019 Q2 -- -- -$0.20 -- --
03/31/2019 Q1 -- -- -$0.20 -- --

Oric Pharmaceuticals, Inc. Earnings Questions

  • How Much did Oric Pharmaceuticals, Inc. Generate in Revenue Last Quarter?

    Oric Pharmaceuticals, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Oric Pharmaceuticals, Inc. Beat Earnings Last Quarter?

    Oric Pharmaceuticals, Inc. announced earnings per share of -$0.33 which represents a beat of analyst forecast a -$0.40 per share.

  • Is Oric Pharmaceuticals, Inc. Profitable?

    Oric Pharmaceuticals, Inc. reported -$288K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Oric Pharmaceuticals, Inc. EPS Next Year?

    Oric Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$1.83 per share to -$1.87 per share next year representing a decrease of -11.23%.

  • When is Oric Pharmaceuticals, Inc.'s Earnings Date?

    Oric Pharmaceuticals, Inc.'s next earnings date is February 17, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock